Allergan Recalls Blephamide Ophthalmic Ointment Due to Impurity Failures
Allergan is recalling 648 units of Blephamide ophthalmic ointment because stability testing showed impurities exceeding specifications.
- Product
- Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.
- Category
- Drug
- Distribution
- Distributed nationwide